Magnesium in chronic haemodialysis (MAGIC-HD): a study protocol for a randomised controlled trial to determine feasibility and safety of using increased dialysate magnesium concentrations to increase plasma magnesium concentrations in people treated with haemodialysis.

Leenders, Nicoline H J; Douma, Caroline E; Hoenderop, Joost G J; Vervloet, Marc G

Leenders, Nicoline H J; Douma, Caroline E; Hoenderop, Joost G J; Vervloet, Marc G.

Affiliation

Leenders NHJ; Department of Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands n.leenders@amsterdamumc.nl.
Douma CE; Department of Physiology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Hoenderop JGJ; Department of Nephrology, Spaarne Gasthuis, Hoofddorp, The Netherlands.
Vervloet MG; Department of Physiology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.

BMJ Open ; 12(11): e063524, 2022 11 21.

Article de En | MEDLINE | ID: mdl-36410806

Sujet(s)
Mots clés

dialysis; end stage renal failure; nephrology

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Solutions de dialyse / Dialyse rénale Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspects: Ethics Limites: Humans Langue: En Journal: BMJ Open Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google